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BSometimes what can be counted doesn't really count and what can not be counted,
does.[ V Albert Einstein
Wi th progressive respiratory muscle weakening, patients with Duchenne muscular dystrophy (DMD) often develop symptomatic hypercapnia during sleep that extends into waking hours and can develop into carbon dioxide (CO 2 ) narcosis, especially when treated with supplemental oxygen. This can be prevented by using noninvasive ventilatory support (NVS) and mechanical insufflation-exsufflation (MIE) as needed instead of oxygen therapy and/or low spans of bilevel positive airway pressure. 1Y4 On the other hand, DMD
patients not introduced to NVS inevitably develop acute respiratory failure (ARF), especially when upper respiratory tract infections develop into pneumonias (URI-pneumonias). This occurs principally because cough flows become inadequate to clear airway secretions. 2, 3 They are then intubated; eventually fail unsupported breathing; undergo tracheotomy; and, in the United States, are then discharged to long-term acute care (LTAC) and/or skilled nursing facility (SNF) ventilator units or return home with 16Y24 hrs per day of skilled nursing care (licensed practical nurse/registered nurse [LPN/RN]) for the rest of their lives. On June 22, 1999 , the United States Supreme Court held in Olmstead v. L.C. (Lois Curtis) that institutionalization of persons with disabilities who might otherwise be managed in the community constitutes discrimination in violation of Title II of the Americans with Disabilities Act and that public entities must offer community-based services to persons with disabilities when feasible. The Olmstead decision justifies home management of patients using long-term mechanical ventilation. 5 Despite this, the population of institutionalized continuous tracheostomy mechanical ventilation (CTMV) users is increasing. 6 An approach that can avoid hospitalization, ARF, tracheostomy, and institutionalization begins by introducing nocturnal noninvasive intermittent positive pressure ventilatory assistance/support (NVS), usually via nasal interface, for symptomatic hypoventilation.This usually occurs when the vital capacity (VC) is approximately 640 ml. 3 As the patients weaken further, VC decreases lower than approximately 400 ml, and they require some daytime NVS. They can usually be switched from using nasal to mouthpiece interfaces for it. With VCs lower than approximately 320 ml, patients tend to depend on NVS continuously (continuous NVS [CNVS] 
METHODS
All DMD patients presenting to one center who became continuously ventilator dependent were retrospectively assessed for long-term disposition and cost of care. No patients were excluded. They were diagnosed by having a typical clinical course including wheelchair dependence before the age of 13 yrs, maximum creatine kinase levels of greater than 5000 IU, and diagnostic muscle biopsy and/or DNA evidence of Xp21 mutation/deletion. Demographics, diagnosisspecific pulmonary function, need for gastrostomy Hospitalization and LTAC reimbursements were derived from diagnosis-related groups (DRGs) data (Table 1) . When intubated patients were not successfully extubated, they underwent tracheotomy and were transferred to SNF ventilator units compensated per diem by Medicaid or they went home with multiple LPNs/RNs assigned to them. 8 The CNVS users were treated in their homes. Any intercurrent intubations were managed by extubation back to CNVS and MIE. They were discharged home directly from the critical care unit. 2 Medicaid waivers (in New Jersey) authorized a fixed sum of money specifically determined for each patient either for unskilled personal assistance services (PASs) for 20Y168 hrs per week or for LPN/RN and/or nurses' aides (Table 1) . Waivers varied from county to county and state to state, but hourly rates were similar. New York Medicaid provides for up to 24 hrs per day of PASs. Patient data were gathered by state (New Jersey, New York, other); years of ventilator dependence (CTMV and/or CNVS); institution vs. home management with publically sponsored PASs, LPN/RN, LPN/RN aides, or no aid; parental/spouse support (0, 1, 2); and presence or absence of GT. These are all factors that might influence disposition and personal care decisions. Group comparisons were made by t test, with P G 0.01 considered significant.
First, massive quantities of data were gathered and compared for the longest invasively (case 1) and noninvasively (case 2) treated patients. Another patient treated long-term by PASs was also chosen for comparison with case 2, whose Medicaid waiver permitted only LPNs/RNs. Finally, the two best documented patients who were decannulated to noninvasive management (cases 4 and 5) were analyzed. Because it became obvious that personal care costs dwarfed all other medical costs, data of the remaining 132 patients were confined to it.
RESULTS
Of 275 patients presenting with DMD, 25 and 108 were treated by CTMV and CNVS, respectively, with 8 additional CTMV users decannulated to CNVS and then considered in the latter category. All had typical DMD clinically, and 37 were diagnosed by DNA analysis; 64, via dystrophin levels and muscle biopsy; and 32, by both. The mean (SD) age was 18.6 (2.3) yrs at tracheotomy, 18.8 (2.4) yrs (P = not significant) at introduction of NVS, and 22.3 (4.7) yrs (P G 0.001) at CNVS. The mean (SD) age at death or last follow-up was 27.3 (5.4) yrs for the 25 CTMV users and 30.4 (5.7) yrs for the 108 CNVS users. Thus, the mean follow-up was 8.7 yrs (range to 29) for the 25 CTMV users and 8.1 yrs (range to 29) for the 108 NVS users. The most recent mean (SD) VC was 174 (145) ml (range, 0Y280) for the CNVS group and 155 (131) ml (range, 0Y330) for the CTMV group.
The 25 CTMV users had never used NVS or MIE, yet 14 lost all ventilator-free breathing ability from the time of tracheotomy. All 16 of the 25 who had GTs had them placed along with tracheotomy. Three of the eight decannulated patients, however, had their GTs removed. Eighteen of the 108 CNVS users, including 5 who had been decannulated, had GTs. Both invasive and noninvasive groups had limb function limited to trace finger as well as minimal neck and facial movements, had insufficient VC for breathing autonomy, and had dysphagia but could speak. Twenty-two of 25 CTMV users and 81 of 93 CNVS users for whom this was known had two involved parents. Of the eight CNVS users with one parent, one had LPN/RN aides, two had PASs, and three had no publically sponsored physical assistance. Four CNVS users in New York lived only with continuous PASs.
Summaries of the detailed assessments of RVUs and expenses for a CTMV user (case 1), two CNVS users (cases 2 and 3), and two CTMV users decannulated to CNVS (cases 4 and 5) are in Table 2 . The complete detailed assessments are available from the corresponding author. The 93 CNVS users for whom it was known had 53 hospitalizations for respiratory complications (0.07 hospitalizations per year), necessitating 38 intubations for 726 patient-years of CNVS. All 38 patients were successfully extubated back to CNVS and discharged home directly from the critical care unit. Intercurrent hospitalization rates for the CTMV users were unavailable. Reviewing Table 2 , it is apparent that costs for physician RVUs, miscellaneous www.ajpmr.com Case 1 is a New Jersey patient hospitalized for ARF at age 19 yrs, failed two extubations, and underwent tracheotomy and gastrostomy. He was then discharged home after 63 days with 16 hrs per day of LPN/RN care for 10 yrs then lived in an SNF ventilator unit all supported by Medicaid until his death after 29 yrs of CTMV at age 48 yrs. After tracheotomy, he had four hospitalizations of 7Y14 days for pneumonias. Case 2 is a New Jersey patient who had annual outpatient visits from ages 17 to 47 yrs, began nocturnal NVS at age 19 yrs with a VC of 700 ml, and began CNVS from age 23 yrs without being hospitalized. He used mouthpiece CNVS during daytime hours. He had four subsequent hospitalizations for URI-pneumonias and was intubated once but successfully extubated to CNVS. (Fig. 1) . He has never been hospitalized for respiratory difficulties. A Medicaid waiver of $2400 per month provides 48 hrs per week of PASs paid $11.45 per hour including benefits. His PASs clean his GT, set up his respirator, and transition him between mouthpiece and nasal CNVS. Case 4, a New Jersey patient born in 1977, had four URI-pneumonias, then, in April 2000, he was intubated for ARF and transferred to an SNF ventilator unit using CTMV with an inflated cuff, was averbal, and was forced to drop out of law school. Five weeks later, he was brought to the authors' clinic, was decannulated to CNVS, developed some ventilator-free breathing ability, and returned home and to law school. He graduated and has remained CNVS dependent for 14 yrs, cared for by two parents with no public assistance other than for respiratory equipment. Case 5 is a Pennsylvania man hospitalized for URI-pneumonias at ages 15 and 26 yrs. After the latter, he returned home with oxygen therapy, developed CO equipment, and intercurrent hospitalizations were negligible by comparison to personal care/facility costs (Table 2) , so only the latter were evaluated for the remaining 132 patients. The 8 decannulated patients and the other 100 NVS users ultimately became CNVS dependent with no ventilator-free breathing ability, but none underwent tracheotomy electively or for extubation failure. Twenty-eight became CNVS dependent without being hospitalized and were not evaluated for home assistance. Because they did not have tracheostomies, they did not want to go there, and SNF units have no expertise in CNVS, CNVS users are not admitted to SNFs. The disposition, personal care needs, and expenses for the 93 CNVS users whose dispositions and personal care needs were known as well as for the CTMV users are in Table 3 .
Eight of the last ten presenting CTMV users including one from an SNF ventilator unit were decannulated to CNVS and MIE despite having VCs ranging from 150 to 380 ml, having little or no ventilator-free breathing ability, and having used CTMV for 1.6 and 1.3 yrs in two cases. After decannulation, several individuals weaned to sleep-only NVS before becoming definitively CNVS dependent 1 yr or more later. After decannulation, the costs were for respiratory equipment only for the five who no longer had any home care despite CNVS dependence for 12, 10, 6.1, 4, and 1.5 yrs but were unchanged for the two for whom 16 
DISCUSSION
A key difference between CTMV and CNVS management was that ARF was inevitable for the former, and, when intubated and unweanable, they underwent tracheotomy. 2, 3, 11 On the other hand, all of the CNVS users, even when intubated, were extubated to CNVS and MIE and discharged using them. Although, conventionally speaking, most clinicians would assume that patients with tracheostomy tubes are more severely affected than those without them, this is clearly not the case for these patients. Only invasive vs. noninvasive management influenced disposition and cost. Cost for invasively treated case 1, with the same severity, years of continuous ventilator dependence, and age at death as case 2, a CNVS user with an LPN/RN, was four times greater ($7 million vs. $1.6 million); it was nine times greater than that for case 3, a CNVS user with PASs for 15 yrs, prorated to an equivalent of 29 yrs of ventilator use ($865,200), and approximately 24 times greater than that for an equivalent CNVS user with public funding only for respiratory ($9,600 per year) and other equipment for approximately $300,000. The cost of treating 25 TMV users for 218 patient-years was approximately the same as that for 93 CNVS users for 726 patient-years ( 2 and oximetry have no current procedural terminology codes. Likewise, there are no specific current procedural terminology codes for extubating or decannulating unweanable patients to NVS and MIE, which can take considerable physician and respiratory therapist time. 6 The extensive patient and family counseling and training, as well as letters of medical necessity and solicitations to payer surrogates to provide respiratory equipment, are also uncompensated. For the five representative patients in Table 2 , invasive management incurred 2Y30 times more RVUs per patient than noninvasive management. Thus, RVUs are considerable and cost astronomical by comparison to effort-intensive noninvasive management. In a 1998 study, it was found that the mean acute, mostly critical care hospital stay for DMD patients undergoing tracheotomy was 72 days. 15 Patient and family reluctance for tracheotomy often leads to multiple extubation failures, ventilator-associated pneumonias, and other complications that prolong critical care stays. Further, although CTMV user hospitalization rates were not available in this study, long-term hospitalization rates for CTMV users have been reported to be significantly higher (P G 0.0001) than for CNVS users.
15
The CTMV users with VCs of 250 ml or more but no ventilator-free breathing ability usually wean to sleep-only NVS once decannulated, as did cases 4 and 5, and do so without LTAC stays. 8 Thus, by noninvasive management, hospitalization, LTAC, and SNF stays as well as complications of tracheostomies 22 and airway suctioning 23 can be completely avoided 3, 15, 22, 24 ; quality-of-life is preserved by living in the community 25 and having prolonged survival 1 ; and noninvasive management is universally preferred by patients. 6, 25 Various consensus groups now promote this approach. 26Y28 As for case 2, mastery of glossopharyngeal breathing can free ventilator users from fear of ventilator failure and accidental disconnection. 21 Further, all this is possible in addition to enormous cost savings. On the other hand, more than 97% of unweanable SNF ventilator (CTMV) users remain institutionalized for life. 2 Does this not beg for a treatment paradigm shift and a proposal to the American Medical Association for new current procedural terminology codes? 29 A decision tree emphasizing this and satisfying the United States Supreme Court's 1999 Olmstead ruling can be seen in Figure 1 .
30Y32
A limitation of this study is that cognitive function was not tested. It is likely, however, that because more patient cooperation is required to use NVS and MIE than TMV, severe mental retardation would hinder it. In addition, it is a limitation that the VCs of the TMV users were not known at the time of tracheotomy. This is the case because all of the patients had undergone tracheotomy before presenting to the authors.
